Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2025-12-29 @ 12:09 AM
Study NCT ID:
NCT04622761
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-01-05
First Post:
2020-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome
Sponsor:
The Clatterbridge Cancer Centre NHS Foundation Trust
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-11-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-29
First Submit QC Date:
None
Study First Post Date:
2020-11-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-04
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL